(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCORE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

ONCORE

ST13

US500000085706751

Class

9, 35, 42

Filing

85706751

Registration

4442331

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

05/27/2024

Trademark type

Combined

Nice classes

9, 35, 42

Filing date

08/17/2012

Registration date

12/03/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2024

Last transaction

05/27/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/17/2012

First use in commerce

08/17/2012

Drawing code

5

Owner type

03

Owner location

Columbia, MD, US

Examiner

KHAN, ASMAT

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ONCORE" in stylized text.

Holders and representatives

Holders

ADVARRA, INC.
ADVARRA TECHNOLOGY SOLUTIONS, INC.
ADVARRA RESEARCH TECHNOLOGIES, INC.
Forte Research Systems, Inc.

Representatives

Andrew J. Ferren Goulston & Storrs PC

Technical classification

Nice Classes

Class 9Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Providing downloadable software for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects and of clinical trials for pharmaceuticalsmedical devices and medical procedures; Providing downloadable software for use by pharmaceutical companies and others in data collectiondata sharinginformation exchangecollaboration regarding scientific and medical research projects and regarding clinical trials for pharmaceuticalsmedical devices and medical procedures

Class 35

Managing databases for use by pharmaceutical companies and others in the design and administration of scientific and medical research projectsof clinical trials for pharmaceuticalsmedical devices and medical procedures; Managing databases for use by pharmaceutical companies and others in the data collectiondata sharinginformation exchangecollaboration regarding scientific and medical research projectsregarding clinical trials for pharmaceuticalsmedical devices and medical procedures

Class 42

Providing on-line non-downloadable software for use in design and administration of scientific and medical research projectsof clinical trials for pharmaceuticalsmedical devices and medical procedures; providing a website featuring non-downloadable software for use in the design and administration of scientific and medical research projectsof clinical trials for pharmaceuticalsmedical devices and medical procedures; Hostingmanagingdevelopingmaintaining web sitessoftwareapplications for use by pharmaceutical companies and others in the design and administration of scientific and medical research projectsof clinical trials for pharmaceuticalsmedical devices and medical procedures; Providing on-line non-downloadable software for use in data collectiondata sharinginformation exchangecollaboration regarding scientific and medical research projectsregarding clinical trials for pharmaceuticalsmedical devices and medical proceduresproviding a website featuring non-downloadable software for use in data collectiondata sharinginformation exchangecollaboration regarding scientific and medical research projectsregarding clinical trials for pharmaceuticalsmedical devices and medical procedures; Hostingmanagingdevelopingmaintaining web sitessoftwareapplicationsdatabases for use by pharmaceutical companies and others in data collectiondata sharinginformation exchangecollaboration regarding scientific and medical research projectsregarding clinical trials for pharmaceuticalsmedical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patientsspecimensequipmentmaterialsfundingschedulesperformance milestones and metrics involved in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical proceduresproviding a website featuring non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patientsspecimensequipmentmaterialsfundingschedulesperformance milestones and metrics involved in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical procedures; Hostingmanagingdevelopingmaintaining web sitessoftwareapplications for use by pharmaceutical companies and others in the tracking and management of patientsspecimensequipmentmaterialsfundingschedulesperformance milestones and metrics involved in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatorystandardssafety compliance in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical proceduresproviding a website featuring non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatorystandardssafety compliance in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical procedures; Hostingmanagingdevelopingmaintaining web sitessoftwareapplications for use by pharmaceutical companies and others in the monitoring and reporting of regulatorystandardssafety compliance in scientific and medical researchin clinical trials for pharmaceuticalsmedical devices and medical procedures; consulting services regarding all of the foregoing

Publications

History of USPTO decisions and trademark events.

46 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/27/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/27/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/27/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/27/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

02/14/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/25/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/03/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/02/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/24/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/24/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/24/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/24/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/24/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/22/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/15/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/08/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/06/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/06/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/30/2019

E815

TEAS SECTION 8 & 15 RECEIVED

10/25/2019

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/18/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/03/2018

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/29/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/17/2013

PUBO

PUBLISHED FOR OPPOSITION

09/17/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/28/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/15/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/14/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

08/14/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/14/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

08/14/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/14/2013

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

08/14/2013

ALIE

ASSIGNED TO LIE

08/07/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/25/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/15/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/15/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/15/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/15/2012

GNRT

NON-FINAL ACTION E-MAILED

12/15/2012

CNRT

NON-FINAL ACTION WRITTEN

12/15/2012

DOCK

ASSIGNED TO EXAMINER

12/12/2012

MPMK

NOTICE OF PSEUDO MARK MAILED

08/28/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/27/2012

NWAP

NEW APPLICATION ENTERED

08/21/2012

Continuous trademark protection

Get notified about every new filing that threatens ONCORE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.